Robert C. Robbins, M. D.

Publications

• Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Nature. 2004; 428 (6983): 668-73
• Trends in invasive disease due to Candida species following heart and lung transplantation. Schaenman JM, Rosso F, Austin JM, Baron EJ, Gamberg P, Miller J, Oyer PE, Robbins RC, Montoya JG. Transpl Infect Dis. 2009; 11 (2): 112-21
• Timing of Bone Marrow Cell Delivery Has Minimal Effects on Cell Viability and Cardiac Recovery Following Myocardial Infarction. Swijnenburg RJ, Govaert JA, van der Bogt KE, Pearl JI, Huang M, Stein W, Hoyt G, Vogel H, Contag CH, Robbins RC, Wu JC. Circ Cardiovasc Imaging. 2009
• Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. van der Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, Govaert JA, Velotta JB, Contag CH, Robbins RC, Wu JC. Transplantation. 2009; 87 (5): 642-52
• Imaging survival and function of transplanted cardiac resident stem cells. Li Z, Lee A, Huang M, Chun H, Chung J, Chu P, Hoyt G, Yang P, Rosenberg J, Robbins RC, Wu JC. J Am Coll Cardiol. 2009; 53 (14): 1229-40
• Imaging gene expression in human mesenchymal stem cells: from small to large animals. Willmann JK, Paulmurugan R, Rodriguez-Porcel M, Stein W, Brinton TJ, Connolly AJ, Nielsen CH, Lutz AM, Lyons J, Ikeno F, Suzuki Y, Rosenberg J, Chen IY, Wu JC, Yeung AC, Yock P, Robbins RC, Gambhir SS. Radiology. 2009; 252 (1): 117-27
• Manganese-guided cellular MRI of human embryonic stem cell and human bone marrow stromal cell viability. Yamada M, Gurney PT, Chung J, Kundu P, Drukker M, Smith AK, Weissman IL, Nishimura D, Robbins RC, Yang PC. Magn Reson Med. 2009; 62 (4): 1047-54
• Effects of cell number on teratoma formation by human embryonic stem cells. Lee AS, Tang C, Cao F, Xie X, van der Bogt K, Hwang A, Connolly AJ, Robbins RC, Wu JC. Cell Cycle. 2009; 8 (16): 2608-12
• Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model. Deuse T, Ikeno F, Robbins RC, Schrepfer S. J Vis Exp. 2009; (31)
• Alternative technique for salvage of donor lungs with insufficient atrial cuffs. Yarbrough WM, Bates MJ, Deuse T, Tang DG, Robbins RC, Reitz BA, Mallidi HR. Ann Thorac Surg. 2009; 88 (4): 1374-6
• Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC, Robbins RC, Schrepfer S. Circulation. 2009; 120 (11 Suppl): S247-54
• Novel minicircle vector for gene therapy in murine myocardial infarction. Huang M, Chen Z, Hu S, Jia F, Li Z, Hoyt G, Robbins RC, Kay MA, Wu JC. Circulation. 2009; 120 (11 Suppl): S230-7
• Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium. Govaert JA, Swijnenburg RJ, Schrepfer S, Xie X, van der Bogt KE, Hoyt G, Stein W, Ransohoff KJ, Robbins RC, Wu JC. J Heart Lung Transplant. 2009; 28 (11): 1158-1165.e1
• Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM, Robbins RC, Longaker MT, Wu JC. Proc Natl Acad Sci U S A. 2009; 106 (37): 15720-5
• The Role of Recipient Mast Cells in Acute and Chronic Cardiac Allograft Rejection in C57BL/6-Kit(W-sh/W-sh) Mice. Itoh S, Nakae S, Velotta JB, Kosuge H, Connolly A, Tsai M, Adachi H, Galli SJ, Robbins RC, Fischbein MP. J Heart Lung Transplant. 2009
• Mechanisms behind Local Immunosuppression Using Inhaled Tacrolimus in Preclinical Models of Lung Transplantation. Deuse T, Blankenberg F, Haddad M, Reichenspurner H, Phillips N, Robbins RC, Schrepfer S. Am J Respir Cell Mol Biol. 2009
• A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection. Velotta JB, Deuse T, Haddad M, Masuda E, Park G, Carroll D, Taylor V, Robbins RC, Schrepfer S. Transplantation. 2009; 87 (5): 653-9
• In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, Hendry SL, Wagner RA, Chen MM, Ali ZA, Yue P, Huynh DT, Connolly AJ, Pelletier MP, Tsao PS, Robbins RC, Quertermous T. Am J Physiol Heart Circ Physiol. 2008; 294 (1): H88-98
• Pneumatic paracorporeal ventricular assist device in infants and children: initial Stanford experience. Malaisrie SC, Pelletier MP, Yun JJ, Sharma K, Timek TA, Rosenthal DN, Wright GE, Robbins RC, Reitz BA. J Heart Lung Transplant. 2008; 27 (2): 173-7
• Introducing the first polymer-free leflunomide eluting stent. Deuse T, Erben RG, Ikeno F, Behnisch B, Boeger R, Connolly AJ, Reichenspurner H, Bergow C, Pelletier MP, Robbins RC, Schrepfer S. Atherosclerosis. 2008; 200 (1): 126-34
• Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection. Deuse T, Velotta JB, Hoyt G, Govaert JA, Taylor V, Masuda E, Herlaar E, Park G, Carroll D, Pelletier MP, Robbins RC, Schrepfer S. Transplantation. 2008; 85 (6): 885-92
• Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778. Deuse T, Hoyt G, Koyanagi T, Robbins RC, Schrepfer S. Transplantation. 2008; 85 (6): 870-7
• In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Swijnenburg RJ, Schrepfer S, Cao F, Pearl JI, Xie X, Connolly AJ, Robbins RC, Wu JC. Stem Cells Dev. 2008; 17 (6): 1023-9
• A novel platform device for rodent echocardiography. Kutschka I, Sheikh AY, Sista R, Hendry SL, Chun HJ, Hoyt G, Kutschka W, Pelletier MP, Quertermous T, Wu JC, Robbins RC. ILAR J. 2008: 49 E1-7
• Twenty-year survivors of heart transplantation at Stanford University. Deuse T, Haddad F, Pham M, Hunt S, Valantine H, Bates MJ, Mallidi HR, Oyer PE, Robbins RC, Reitz BA. Am J Transplant. 2008; 8 (9): 1769-74
• Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Swijnenburg RJ, Schrepfer S, Govaert JA, Cao F, Ransohoff K, Sheikh AY, Haddad M, Connolly AJ, Davis MM, Robbins RC, Wu JC. Proc Natl Acad Sci U S A. 2008; 105 (35): 12991-6
• Short hairpin RNA interference therapy for ischemic heart disease. Huang M, Chan DA, Jia F, Xie X, Li Z, Hoyt G, Robbins RC, Chen X, Giaccia AJ, Wu JC. Circulation. 2008; 118 (14 Suppl): S226-33
• Comparison of different adult stem cell types for treatment of myocardial ischemia. van der Bogt KE, Sheikh AY, Schrepfer S, Hoyt G, Cao F, Ransohoff KJ, Swijnenburg RJ, Pearl J, Lee A, Fischbein M, Contag CH, Robbins RC, Wu JC. Circulation. 2008; 118 (14 Suppl): S121-9
• Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. Cao F, Wagner RA, Wilson KD, Xie X, Fu JD, Drukker M, Lee A, Li RA, Gambhir SS, Weissman IL, Robbins RC, Wu JC. PLoS One. 2008; 3 (10): e3474
• Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells. Hendry SL, van der Bogt KE, Sheikh AY, Arai T, Dylla SJ, Drukker M, McConnell MV, Kutschka I, Hoyt G, Cao F, Weissman IL, Connolly AJ, Pelletier MP, Wu JC, Robbins RC, Yang PC. J Thorac Cardiovasc Surg. 2008; 136 (4): 1028-1037.e1
• Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Cao F, van der Bogt KE, Sadrzadeh A, Xie X, Sheikh AY, Wang H, Connolly AJ, Robbins RC, Wu JC. Stem Cells Dev. 2007; 16 (6): 883-91
• Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. Xie X, Cao F, Sheikh AY, Li Z, Connolly AJ, Pei X, Li RK, Robbins RC, Wu JC. Cloning Stem Cells. 2007; 9 (4): 549-63
• Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP, Wu JC. Circulation. 2007; 116 (11 Suppl): I46-54
• Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis. Choi JY, Joo NS, Krouse ME, Wu JV, Robbins RC, Ianowski JP, Hanrahan JW, Wine JJ. J Clin Invest. 2007; 117 (10): 3118-27
• Current trends in heart transplantation. Balsam LB, Robbins RC. Scand J Surg. 2007; 96 (2): 125-30
• Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Sheikh AY, Lin SA, Cao F, Cao Y, van der Bogt KE, Chu P, Chang CP, Contag CH, Robbins RC, Wu JC. Stem Cells. 2007; 25 (10): 2677-84
• Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model. Koyanagi T, Noguchi K, Ootani A, Inagaki K, Robbins RC, Mochly-Rosen D. J Mol Cell Cardiol. 2007; 43 (4): 517-22
• Positron emission tomography imaging of conditional gene activation in the heart. Chang GY, Cao F, Krishnan M, Huang M, Li Z, Xie X, Sheikh AY, Hoyt G, Robbins RC, Hsiai T, Schneider MD, Wu JC. J Mol Cell Cardiol. 2007; 43 (1): 18-26
• Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease. Schrepfer S, Deuse T, Reichenspurner H, Hoffmann J, Haddad M, Fink J, Fischbein MP, Robbins RC, Pelletier MP. Am J Transplant. 2007; 7 (7): 1733-42
• In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides. Suzuki Y, Zhang S, Kundu P, Yeung AC, Robbins RC, Yang PC. Magn Reson Med. 2007; 57 (6): 1173-9
• Stem cell transplantation: the lung barrier. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Transplant Proc. 2007; 39 (2): 573-6
• In vivo optical bioluminescence imaging of collagen-supported cardiac cell grafts. Kutschka I, Chen IY, Kofidis T, von Degenfeld G, Sheikh AY, Hendry SL, Hoyt G, Pearl J, Blau HM, Gambhir SS, Robbins RC. J Heart Lung Transplant. 2007; 26 (3): 273-80
• Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells. Schrepfer S, Deuse T, Lange C, Katzenberg R, Reichenspurner H, Robbins RC, Pelletier MP. Stem Cells Dev. 2007; 16 (1): 105-7
• Experimental orthotopic tracheal transplantation: The Stanford technique. Schrepfer S, Deuse T, Hoyt G, Sheikh AY, Hoffmann J, Reichenspurner H, Robbins RC, Pelletier MP. Microsurgery. 2007; 27 (3): 187-9
• Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. Yue P, Arai T, Terashima M, Sheikh AY, Cao F, Charo D, Hoyt G, Robbins RC, Ashley EA, Wu J, Yang PC, Tsao PS. Am J Physiol Heart Circ Physiol. 2007; 292 (5): H2106-18
• Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Kuppahally SS, Valantine HA, Weisshaar D, Parekh H, Hung YY, Haddad F, Fowler M, Vagelos R, Perlroth MG, Robbins RC, Hunt SA. Am J Transplant. 2007; 7 (10): 2388-95
• Hyposecretion, not hyperabsorption, is the basic defect of cystic fibrosis airway glands. Joo NS, Irokawa T, Robbins RC, Wine JJ. J Biol Chem. 2006; 281 (11): 7392-8
• Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Kutschka I, Chen IY, Kofidis T, Arai T, von Degenfeld G, Sheikh AY, Hendry SL, Pearl J, Hoyt G, Sista R, Yang PC, Blau HM, Gambhir SS, Robbins RC. Circulation. 2006; 114 (1 Suppl): I167-73
• Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Kutschka I, Kofidis T, Chen IY, von Degenfeld G, Zwierzchoniewska M, Hoyt G, Arai T, Lebl DR, Hendry SL, Sheikh AY, Cooke DT, Connolly A, Blau HM, Gambhir SS, Robbins RC. Circulation. 2006; 114 (1 Suppl): I174-80
• Virtual angioscopy in type-A dissection: ascending aortic stent-graft repair. Verhoye JP, Sze DY, Ihnken K, Hellinger JC, Robbins RR, Dake MD. Ann Thorac Surg. 2006; 82 (1): 347
• Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Kuppahally S, Al-Khaldi A, Weisshaar D, Valantine HA, Oyer P, Robbins RC, Hunt SA. Am J Transplant. 2006; 6 (5 Pt 1): 986-92
• Outcome analysis of donor gender in heart transplantation. Al-Khaldi A, Oyer PE, Robbins RC. J Heart Lung Transplant. 2006; 25 (4): 461-8
• Ten- and 20-year survivors of pediatric orthotopic heart transplantation. Ross M, Kouretas P, Gamberg P, Miller J, Burge M, Reitz B, Robbins R, Chin C, Bernstein D. J Heart Lung Transplant. 2006; 25 (3): 261-70
• Successful repair of blunt injury of aortic arch branches in the setting of bovine arch. Al-Khaldi A, Robbins RC. J Vasc Surg. 2006; 43 (2): 396-8
• Successful bridge to transplant using the Berlin Heart left ventricular assist device in a 3-month-old infant. Dunnington GH, Sleasman J, Alkhaldi A, Pelletier MP, Reitz BA, Robbins RC. Ann Thorac Surg. 2006; 81 (3): 1116-8
• New directions in cardiac transplantation. Al-khaldi A, Robbins RC. Annu Rev Med. 2006: 57 455-71
• Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? Moffatt-Bruce SD, Karamichalis J, Robbins RC, Whyte RI, Theodore J, Reitz BA. Ann Thorac Surg. 2006; 81 (1): 286-91; discussion 291
• Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. Wu JC, Spin JM, Cao F, Lin S, Xie X, Gheysens O, Chen IY, Sheikh AY, Robbins RC, Tsalenko A, Gambhir SS, Quertermous T. Physiol Genomics. 2006; 25 (1): 29-38
• Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 t. Arai T, Kofidis T, Bulte JW, de Bruin J, Venook RD, Berry GJ, Mcconnell MV, Quertermous T, Robbins RC, Yang PC. Magn Reson Med. 2006; 55 (1): 203-9
• Thoratec ventricular assist devices in pediatric patients: update on clinical results. Reinhartz O, Hill JD, Al-Khaldi A, Pelletier MP, Robbins RC, Farrar DJ. ASAIO J. 2005 Sep-Oct; 51 (5): 501-3
• Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC. Circulation. 2005; 112 (9 Suppl): I173-7
• Caspase-3 inhibition preserves myocardial geometry and long-term function after infarction. Balsam LB, Kofidis T, Robbins RC. J Surg Res. 2005; 124 (2): 194-200
• Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators. Tanaka M, Gunawan F, Terry RD, Inagaki K, Caffarelli AD, Hoyt G, Tsao PS, Mochly-Rosen D, Robbins RC. J Thorac Cardiovasc Surg. 2005; 129 (5): 1160-7
• Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Kofidis T, de Bruin JL, Yamane T, Tanaka M, Lebl DR, Swijnenburg RJ, Weissman IL, Robbins RC. Circulation. 2005; 111 (19): 2486-93
• Progression of alloresponse and tissue-specific immunity during graft coronary artery disease. Tanaka M, Zwierzchoniewska M, Mokhtari GK, Terry RD, Balsam LB, Robbins RC, Fedoseyeva EV. Am J Transplant. 2005; 5 (6): 1286-96
• Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Cao YA, Bachmann MH, Beilhack A, Yang Y, Tanaka M, Swijnenburg RJ, Reeves R, Taylor-Edwards C, Schulz S, Doyle TC, Fathman CG, Robbins RC, Herzenberg LA, Negrin RS, Contag CH. Transplantation. 2005; 80 (1): 134-9
• Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease. Balsam LB, Mokhtari GK, Jones S, Peterson S, Hoyt EG, Kofidis T, Tanaka M, Cooke DT, Robbins RC. J Heart Lung Transplant. 2005; 24 (7): 827-32
• They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Kofidis T, deBruin JL, Tanaka M, Zwierzchoniewska M, Weissman I, Fedoseyeva E, Haverich A, Robbins RC. Eur J Cardiothorac Surg. 2005; 28 (3): 461-6
• Graft coronary artery disease in murine cardiac allografts: proposal to meet the need for standardized assessment. Tanaka M, Fedoseyeva EV, Robbins RC. J Heart Lung Transplant. 2005; 24 (3): 316-22
• Lung transplantation: a decade of experience. Moffatt SD, Demers P, Robbins RC, Doyle R, Wienacker A, Henig N, Theodore J, Reitz BA, Whyte RI. J Heart Lung Transplant. 2005; 24 (2): 145-51
• Successful repair of tracheal dehiscence after heart-lung transplantation. Pelletier MP, Coady M, Ahmed S, Lamb J, Reitz BA, Robbins RC. J Heart Lung Transplant. 2005; 24 (1): 99-101
• Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab. Chin C, Pittson S, Luikart H, Bernstein D, Robbins R, Reitz B, Oyer P, Valantine H. Transplantation. 2005; 80 (4): 477-81
• The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, Caffarelli A, Deng A, Eichhorn J, Mahajan R, Agrawal R, Greve J, Robbins R, Patterson AJ, Bernstein D, Quertermous T. Cardiovasc Res. 2005; 65 (1): 73-82
• Pre-transplant blood transfusion and cyclosporin A induce long-term hamster cardiac xenograft survival in immunocompetent rats. Vriens PW, Stoot JH, van der Steenhoven TJ, Hoyt G, Bouwman E, Robbins RC. Xenotransplantation. 2005; 12 (1): 63-71
• Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. Kofidis T, de Bruin JL, Hoyt G, Ho Y, Tanaka M, Yamane T, Lebl DR, Swijnenburg RJ, Chang CP, Quertermous T, Robbins RC. J Heart Lung Transplant. 2005; 24 (6): 737-44
• Haematopoietic stem cells and repair of the ischaemic heart. Balsam LB, Robbins RC. Clin Sci (Lond). 2005; 109 (6): 483-92
• Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion. Tanaka M, Mokhtari GK, Terry RD, Gunawan F, Balsam LB, Hoyt G, Lee KH, Tsao PS, Robbins RC. J Heart Lung Transplant. 2005; 24 (11): 1906-14
• Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. Tanaka M, Sydow K, Gunawan F, Jacobi J, Tsao PS, Robbins RC, Cooke JP. Circulation. 2005; 112 (11): 1549-56
• In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging. Tanaka M, Swijnenburg RJ, Gunawan F, Cao YA, Yang Y, Caffarelli AD, de Bruin JL, Contag CH, Robbins RC. Circulation. 2005; 112 (9 Suppl): I105-10
• Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model. Tanaka M, Mokhtari GK, Balsam LB, Cooke DT, Kofidis T, Zwierzchonievska M, Robbins RC. J Heart Lung Transplant. 2005; 24 (4): 446-53
• Overexpression of human Bcl-2 in syngeneic rat donor lungs preserves posttransplant function and reduces intragraft caspase activity and interleukin-1beta production. Cooke DT, Hoyt EG, Robbins RC. Transplantation. 2005; 79 (7): 762-7
• Overexpression of human copper/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts. Tanaka M, Mokhtari GK, Terry RD, Balsam LB, Lee KH, Kofidis T, Tsao PS, Robbins RC. Circulation. 2004; 110 (11 Suppl 1): II200-6
• Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts. Tanaka M, Terry RD, Mokhtari GK, Inagaki K, Koyanagi T, Kofidis T, Mochly-Rosen D, Robbins RC. Circulation. 2004; 110 (11 Suppl 1): II194-9
• Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease. Tanaka M, Nakae S, Terry RD, Mokhtari GK, Gunawan F, Balsam LB, Kaneda H, Kofidis T, Tsao PS, Robbins RC. Blood. 2004; 104 (12): 3789-96
• Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis. Murata S, Sundell CL, Lijkwan MA, Balsam LB, Hammainen P, Coleman C, York C, Luchoomun J, Suen KL, Howard R, Somers PK, Morris RE, Robbins RC. Transplantation. 2004; 77 (10): 1494-500
• Successful treatment of a Stanford type A dissection by percutaneous placement of a covered stent graft in the ascending aorta. Ihnken K, Sze D, Dake MD, Fleischmann D, Van der Starre P, Robbins R. J Thorac Cardiovasc Surg. 2004; 127 (6): 1808-10
• Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation. Fearon WF, Aarnoudse W, Pijls NH, De Bruyne B, Balsam LB, Cooke DT, Robbins RC, Fitzgerald PJ, Yeung AC, Yock PG. Circulation. 2004; 109 (19): 2269-72
• Chylothorax after heart/lung transplantation. Ziedalski TM, Raffin TA, Sze DY, Mitchell JD, Robbins RC, Theodore J, Faul JL. J Heart Lung Transplant. 2004; 23 (5): 627-31
• Will minimally invasive valve replacement ever really be important? Caffarelli AD, Robbins RC. Curr Opin Cardiol. 2004; 19 (2): 123-7
• Distinct cell-to-fiber junctions are critical for the establishment of cardiotypical phenotype in a 3D bioartificial environment. Kofidis T, Balsam L, de Bruin J, Robbins RC. Med Eng Phys. 2004; 26 (2): 157-63
• Gastric pacing for severe gastroparesis in a heart-lung transplant recipient. Yiannopoulos A, Shafazand S, Ziedalski T, Berry GJ, Robbins RC, Theodore J, Faul JL. J Heart Lung Transplant. 2004; 23 (3): 371-4
• Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data. Rosenthal DN, Chin C, Nishimura K, Perry SB, Robbins RC, Reitz B, Bernstein D, Feinstein JA. J Heart Lung Transplant. 2004; 23 (3): 323-9
• Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. Shiba N, Chan MC, Kwok BW, Valantine HA, Robbins RC, Hunt SA. J Heart Lung Transplant. 2004; 23 (2): 155-64
• Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation. Soccal PM, Gasche Y, Miniati DN, Hoyt G, Berry GJ, Doyle RL, Theodore J, Robbins RC. Am J Transplant. 2004; 4 (1): 41-50
• Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Kofidis T, de Bruin JL, Yamane T, Balsam LB, Lebl DR, Swijnenburg RJ, Tanaka M, Weissman IL, Robbins RC. Stem Cells. 2004; 22 (7): 1239-45
• Superoxide dismutase mimetic m40401 reduces ischemia-reperfusion injury and graft coronary artery disease in rodent cardiac allografts. Murata S, Miniati DN, Kown MH, Koransky ML, Lijkwan MA, Balsam LB, Robbins RC. Transplantation. 2004; 78 (8): 1166-71
• Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914. Lam TT, Hausen B, Boeke-Purkis K, Paniagua R, Lau M, Hook L, Berry G, Higgins J, Duthaler RO, Katopodis AG, Robbins R, Reitz B, Borie D, Schuurman HJ, Morris RE. Xenotransplantation. 2004; 11 (6): 517-24
• Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. Kofidis T, de Bruin JL, Hoyt G, Lebl DR, Tanaka M, Yamane T, Chang CP, Robbins RC. J Thorac Cardiovasc Surg. 2004; 128 (4): 571-8
• The value of transesophageal echocardiography for endovascular graft stenting of the ascending aorta. van der Starre P, Guta C, Dake M, Ihnken K, Robbins R. J Cardiothorac Vasc Anesth. 2004; 18 (4): 466-8
• Bcl-2-mediated inhibition of apoptosis in rat cardiac allografts worsens development of graft coronary artery disease. Kown MH, Miniati DN, Jahncke CL, Lijkwan MA, Murata S, Koransky ML, Blankenberg FG, Strauss HW, Robbins RC. J Heart Lung Transplant. 2003; 22 (9): 986-92
• Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation. Pelletier MP, Coady M, Macha M, Oyer PE, Robbins RC. J Heart Lung Transplant. 2003; 22 (2): 124-9
• Invasive aspergillosis in the setting of cardiac transplantation. Montoya JG, Chaparro SV, Celis D, Cortés JA, Leung AN, Robbins RC, Stevens DA. Clin Infect Dis. 2003: 37 Suppl 3 S281-92
• Comparison of developmental endothelial locus-1 angiogenic factor with vascular endothelial growth factor in a porcine model of cardiac ischemia. Kown MH, Suzuki T, Koransky ML, Penta K, Sakamoto G, Jahncke CL, Carter AJ, Quertermous T, Robbins RC. Ann Thorac Surg. 2003; 76 (4): 1246-51
• Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. Shiba N, Chan MC, Valantine HA, Gao SZ, Robbins RC, Hunt SA. J Heart Lung Transplant. 2003; 22 (10): 1098-106
• L-Arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats. Kown MH, Lijkwan MA, Jahncke CL, Murata S, Rothbard JB, Robbins RC. J Thorac Cardiovasc Surg. 2003; 126 (4): 1065-70
• Comparison of coronary thermodilution and Doppler velocity for assessing coronary flow reserve. Fearon WF, Farouque HM, Balsam LB, Caffarelli AD, Cooke DT, Robbins RC, Fitzgerald PJ, Yeung AC, Yock PG. Circulation. 2003; 108 (18): 2198-200
• Acute type A aortic dissection complicated by aortic regurgitation: composite valve graft versus separate valve graft versus conservative valve repair. Lai DT, Miller DC, Mitchell RS, Oyer PE, Moore KA, Robbins RC, Shumway NE, Reitz BA. J Thorac Cardiovasc Surg. 2003; 126 (6): 1978-86
• Quantification of mechanical stabilization for the performance of off-pump coronary artery surgery. Koransky ML, Tavana ML, Yamaguchi A, Kown MH, Miniati DN, Nowlin W, Robbins RC. Heart Surg Forum. 2003; 6 (4): 224-31
• Effects of adenoviral up-regulation of bcl-2 on oxidative stress and graft coronary artery disease in rat heart transplants. Miniati DN, Lijkwan MA, Murata S, Martens J, Coleman CT, Hoyt EG, Robbins RC. Transplantation. 2003; 76 (2): 382-6
• Long-term results of heart transplantation in patients older than 60 years. Demers P, Moffatt S, Oyer PE, Hunt SA, Reitz BA, Robbins RC. J Thorac Cardiovasc Surg. 2003; 126 (1): 224-31
• Elevated cyclic adenosine monophosphate ameliorates ischemia-reperfusion injury in rat cardiac allografts. Murata S, Miniati DN, Kown MH, Koransky ML, Balsam LB, Lijkwan MA, Martens JM, Robbins RC. J Heart Lung Transplant. 2003; 22 (7): 802-9
• Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. Kofidis T, Akhyari P, Wachsmann B, Mueller-Stahl K, Boublik J, Ruhparwar A, Mertsching H, Balsam L, Robbins R, Haverich A. Tissue Eng. 2003; 9 (3): 517-23
• Antegrade versus retrograde perfusion of the donor lung: impact on the early reperfusion phase. Kofidis T, Strüber M, Warnecke G, Sommer S, Leyh RG, Balsam LB, Robbins RC, Haverich A. Transpl Int. 2003; 16 (11): 801-5
• Novel index for invasively assessing the coronary microcirculation. Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC. Circulation. 2003; 107 (25): 3129-32
• Antisense oligonucleotides: design, construction, and applications to cardiac allograft transfer. Balsam LB, Miniati DN, Robbins RC. Methods Mol Biol. 2003: 219 129-33
• Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, Ben-Dor A, Fenster B, Yang E, King JY, Fowler M, Robbins R, Johnson FL, Bruhn L, McDonagh T, Dargie H, Yakhini Z, Tsao PS, Quertermous T. Circulation. 2003; 108 (12): 1432-9
• Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury. Falk V, Soccal PM, Grünenfelder J, Hoyt G, Walther T, Robbins RC. Eur J Cardiothorac Surg. 2002; 22 (1): 53-8
• Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the Stanford experience. Vricella LA, Karamichalis JM, Ahmad S, Robbins RC, Whyte RI, Reitz BA. Ann Thorac Surg. 2002; 74 (1): 13-7; discussion 17-8
• The use of (99m)technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts. Kown MH, Jahncke CL, Lijkwan MA, Koransky ML, Mari C, Berry GJ, Blankenberg FG, Strauss HW, Robbins RC. J Heart Lung Transplant. 2002; 21 (9): 1009-15
• Does profound hypothermic circulatory arrest improve survival in patients with acute type a aortic dissection? Lai DT, Robbins RC, Mitchell RS, Moore KA, Oyer PE, Shumway NE, Reitz BA, Miller DC. Circulation. 2002; 106 (12 Suppl 1): I218-28
• Absent secretion to vasoactive intestinal peptide in cystic fibrosis airway glands. Joo NS, Irokawa T, Wu JV, Robbins RC, Whyte RI, Wine JJ. J Biol Chem. 2002; 277 (52): 50710-5
• Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections? Umaña JP, Lai DT, Mitchell RS, Moore KA, Rodriguez F, Robbins RC, Oyer PE, Dake MD, Shumway NE, Reitz BA, Miller DC. J Thorac Cardiovasc Surg. 2002; 124 (5): 896-910
• Donor cardiac allografts from p53 knockout mice exhibit apoptosis-independent prolongation of survival. Kown MH, Murata S, Jahncke CL, Mari C, Berry GJ, Lijkwan MA, Blankenberg FG, Strauss HW, Robbins RC. Transplant Proc. 2002; 34 (8): 3274-6
• Restoration of blood flow and evaluation of corresponding angiogenic events by scanning electron microscopy after a single dose of VEGF in a model of peripheral vascular disease. Kofidis T, Nolte D, Simon AR, Metzakis A, Balsam L, Robbins R, Haverich A. Angiogenesis. 2002; 5 (1-2): 87-92
• Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients. Chin C, Hunt S, Robbins R, Hoppe R, Reitz B, Bernstein D. J Heart Lung Transplant. 2002; 21 (6): 667-73
• Heart transplantation: a thirty-year perspective. Miniati DN, Robbins RC. Annu Rev Med. 2002: 53 189-205
• Up-regulation of Bcl-2 through hyperbaric pressure transfection of TGF-beta1 ameliorates ischemia-reperfusion injury in rat cardiac allografts. Grünenfelder J, Miniati DN, Murata S, Falk V, Hoyt EG, Robbins RC. J Heart Lung Transplant. 2002; 21 (2): 244-50
• Zinc chloride-mediated reduction of apoptosis as an adjunct immunosuppressive modality in cardiac transplantation. Kown MH, van der Steenhoven TJ, Jahncke CL, Mari C, Lijkwan MA, Koransky ML, Blankenberg FG, Strauss HW, Robbins RC. J Heart Lung Transplant. 2002; 21 (3): 360-5
• Alternative approach for use of a left ventricular assist device with a thrombosed prosthetic valve. Pelletier MP, Chang CP, Vagelos R, Robbins RC. J Heart Lung Transplant. 2002; 21 (3): 402-4
• Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model. Yamaguchi A, Miniati DN, Hirata K, Hoyt EG, Robbins RC. J Heart Lung Transplant. 2002; 21 (4): 417-24
• VEGF gene delivery for treatment of ischemic cardiovascular disease. Koransky ML, Robbins RC, Blau HM. Trends Cardiovasc Med. 2002; 12 (3): 108-14
• Techniques in orthotopic cardiac transplantation: a review. Miniati DN, Robbins RC. Cardiol Rev. 2001 May-Jun; 9 (3): 131-6
• Xeno-tolerance induced by blood transfusion in athymic nude rats. Vriens PW, Stoot JH, Bouwman E, Robbins RC. Transplant Proc. 2001 Feb-Mar; 33 (1-2): 791
• Pre-transplant blood transfusion induces tolerance to hamster cardiac xenografts in athymic nude rats. Vriens PW, Stoot JH, Hoyt G, Scheringa M, Bouwman E, Robbins RC. Xenotransplantation. 2001; 8 (4): 247-57
• Hamster cardiac xenografts are protected against antibody mediated damage, early after transplantation to Lewis rats. Vriens PW, Pollard JD, Hoyt G, Morris RE, Scheringa M, Bouwman E, Robbins RC. Xenotransplantation. 2001; 8 (4): 239-46
• Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone. Valantine HA, Luikart H, Doyle R, Theodore J, Hunt S, Oyer P, Robbins R, Berry G, Reitz B. Transplantation. 2001; 72 (10): 1647-52
• Upregulation of Bcl-2 through caspase-3 inhibition ameliorates ischemia/reperfusion injury in rat cardiac allografts. Grünenfelder J, Miniati DN, Murata S, Falk V, Hoyt EG, Kown M, Koransky ML, Robbins RC. Circulation. 2001; 104 (12 Suppl 1): I202-6
• Severe tricuspid regurgitation after heart transplantation. Chan MC, Giannetti N, Kato T, Kornbluth M, Oyer P, Valantine HA, Robbins RC, Hunt SA. J Heart Lung Transplant. 2001; 20 (7): 709-17
• L-arginine polymer mediated inhibition of graft coronary artery disease after cardiac transplantation. Kown MH, van Der Steenhoven T, Uemura S, Jahncke CL, Hoyt GE, Rothbard JB, Robbins RC. Transplantation. 2001; 71 (11): 1542-8
• Photodynamic therapy with motexafin lutetium (Lu-Tex) reduces experimental graft coronary artery disease. Yamaguchi A, Woodburn KW, Hayase M, Hoyt G, Robbins RC. Transplantation. 2001; 71 (11): 1526-32
• L-arginine polymers inhibit the development of vein graft neointimal hyperplasia. Kown MH, Yamaguchi A, Jahncke CL, Miniati D, Murata S, Grunenfelder J, Koransky ML, Rothbard JB, Robbins RC. J Thorac Cardiovasc Surg. 2001; 121 (5): 971-80
• Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Moon MR, Miller DC, Moore KA, Oyer PE, Mitchell RS, Robbins RC, Stinson EB, Shumway NE, Reitz BA. Ann Thorac Surg. 2001; 71 (4): 1164-71
• The totally implantable novacor left ventricular assist system. Robbins RC, Kown MH, Portner PM, Oyer PE. Ann Thorac Surg. 2001; 71 (3 Suppl): S162-5; discussion S183-4
• Upregulation of BCL-2 via hyperbaric pressure transfection of TGF- beta1 ameliorates ischemia/reperfusion injury in rat cardiac allografts. Grunenfelder J, Miniati D, Murata S, Kown M, Falk V, Hoyt EG, Koransky M, Robbins R. J Heart Lung Transplant. 2001; 20 (2): 154
• Oxidative stress of cardiac transplantation is associated with decreased BCL-2 expression and increased NFKB activity. Miniati DN, Grunenfelder J, Hoyt EG, Murata S, Kown M, Koransky M, Robbins R. J Heart Lung Transplant. 2001; 20 (2): 158-159
• TC99M MCP-1 imaging of chronic rejection in rat cardiac allografts. Kown MH, Blankenberg FG, Strauss HW, Hoyt GE, Robbins RC. J Heart Lung Transplant. 2001; 20 (2): 186
• In vivo monitoring of myoblast transplantation into rat myocardium. Koransky ML, Ip TK, Wu S, Cao Y, Berry G, Contag C, Blau H, Robbins R. J Heart Lung Transplant. 2001; 20 (2): 188-189
• Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis. Egan TM, Bennett LE, Garrity ER, Grover FL, Ring WS, Robbins RC, Trulock E, Wood DE. J Heart Lung Transplant. 2001; 20 (2): 242
• In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin V. Kown MH, Strauss HW, Blankenberg FG, Berry GJ, Stafford-Cecil S, Tait JF, Goris ML, Robbins RC. Am J Transplant. 2001; 1 (3): 270-7
• The Novacor left ventricular assist system: clinical experience from the Novacor registry. Dagenais F, Portner PM, Robbins RC, Oyer PE. J Card Surg. 2001; 16 (4): 267-71
• Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation. Pelletier MP, Coady M, Macha M, Oyer PE, Robbins RC. J Heart Lung Transplant. 2001; 20 (2): 152
• Mechanical support for acutely failed heart or lung grafts. Miniati DN, Robbins RC. J Card Surg. 2000 Mar-Apr; 15 (2): 129-35
• Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability. Hausen B, Ikonen T, Briffa N, Berry GJ, Christians U, Robbins RC, Hook L, Serkova N, Benet LZ, Schuler W, Morris RE. Transplantation. 2000; 69 (1): 76-86
• Nuclear factor-kappaB transcription factor decoy treatment inhibits graft coronary artery disease after cardiac transplantation in rodents. Feeley BT, Miniati DN, Park AK, Hoyt EG, Robbins RC. Transplantation. 2000; 70 (11): 1560-8
• Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model. Yamaguchi A, Woodburn KW, Hayase M, Robbins RC. Circulation. 2000; 102 (19 Suppl 3): III275-80
• Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease. Miniati DN, Hoyt EG, Feeley BT, Poston RS, Robbins RC. Circulation. 2000; 102 (19 Suppl 3): III237-42
• Zinc-mediated reduction of apoptosis in cardiac allografts. Kown MH, Van der Steenhoven T, Blankenberg FG, Hoyt G, Berry GJ, Tait JF, Strauss HW, Robbins RC. Circulation. 2000; 102 (19 Suppl 3): III228-32
• Multidimensional assessment of graft vascular disease (GVD) in aortic grafts by serial intravascular ultrasound in rhesus monkeys. Ikonen TS, Briffa N, Gummert JF, Honda Y, Hayase M, Hausen B, Billingham ME, Yock PG, Robbins RC, Morris RE. Transplantation. 2000; 70 (3): 420-9
• Norman E. Shumway. Robbins RC, Clin Cardiol. 2000; 23 (6): 462-6
• Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients. Poston RS, Robbins RC, Chan B, Simms P, Presta L, Jardieu P, Morris RE. Transplantation. 2000; 69 (10): 2005-13
• A report of two hundred twenty cases of regional anesthesia in pediatric cardiac surgery. Peterson KL, DeCampli WM, Pike NA, Robbins RC, Reitz BA. Anesth Analg. 2000; 90 (5): 1014-9
• Optimization of ex vivo pressure mediated delivery of antisense oligodeoxynucleotides to ICAM-1 reduces reperfusion injury in rat cardiac allografts. Feeley BT, Poston RS, Park AK, Ennen MP, Hoyt EG, Vriens PW, Robbins RC. Transplantation. 2000; 69 (6): 1067-74
• Radionuclide imaging of acute lung transplant rejection with annexin V. Blankenberg FG, Robbins RC, Stoot JH, Vriens PW, Berry GJ, Tait JF, Strauss HW. Chest. 2000; 117 (3): 834-40
• Heart-lung versus double-lung transplantation for suppurative lung disease. Barlow CW, Robbins RC, Moon MR, Akindipe O, Theodore J, Reitz BA. J Thorac Cardiovasc Surg. 2000; 119 (3): 466-76
• New Approaches and Conduits: In Situ Venous Arterialization and Coronary Artery Bypass. Fitzgerald PJ, Hayase M, Yeung AC, Virmani R, Robbins RC, Burkhoff D, Makower J, Yock PG, Oesterle SN. Curr Interv Cardiol Rep. 1999; 1 (2): 127-137
• Cervical aortic arch with pseudocoarctation: presentation with spontaneous rupture. Ikonomidis JS, Robbins RC. Ann Thorac Surg. 1999; 67 (1): 248-50
• Thirty years of cardiac transplantation at Stanford university. Robbins RC, Barlow CW, Oyer PE, Hunt SA, Miller JL, Reitz BA, Stinson EB, Shumway NE. J Thorac Cardiovasc Surg. 1999; 117 (5): 939-51
• Heart-lung transplantation for primary pulmonary hypertension. Whyte RI, Robbins RC, Altinger J, Barlow CW, Doyle R, Theodore J, Reitz BA. Ann Thorac Surg. 1999; 67 (4): 937-41; discussion 941-2
• Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Poston RS, Billingham M, Hoyt EG, Pollard J, Shorthouse R, Morris RE, Robbins RC. Circulation. 1999; 100 (1): 67-74
• Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants. Feeley BT, Park AK, Hoyt EG, Robbins RC. J Heart Lung Transplant. 1999; 18 (11): 1088-95
• Bridge to transplant with the Novacor left ventricular assist system. Robbins RC, Oyer PE. Ann Thorac Surg. 1999; 68 (2): 695-7
• Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. Poston RS, Mann MJ, Hoyt EG, Ennen M, Dzau VJ, Robbins RC. Transplantation. 1999; 68 (6): 825-32
• ICAM-1 affects reperfusion injury and graft function after cardiac transplantation. Poston RS, Ing DJ, Ennen MP, Hoyt EG, Robbins RC. J Surg Res. 1999; 87 (1): 25-31
• The use of advanced-age donor hearts adversely affects survival in pediatric heart transplantation. Chin C, Miller J, Robbins R, Reitz B, Bernstein D. Pediatr Transplant. 1999; 3 (4): 309-14
• Pressure delivery of AS-ICAM-1 ODN with LFA-1 mAb reduces reperfusion injury in cardiac allografts. Feeley BT, Park AK, Alexopoulos S, Hoyt EG, Ennen MP, Poston RS, Robbins RC. Ann Thorac Surg. 1999; 68 (1): 119-24
• Arrhythmias and thromboembolic complications after the extracardiac Fontan operation. Shirai LK, Rosenthal DN, Reitz BA, Robbins RC, Dubin AM. J Thorac Cardiovasc Surg. 1998; 115 (3): 499-505
• Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides. Poston RS, Tran KP, Mann MJ, Hoyt EG, Dzau VJ, Robbins RC. J Heart Lung Transplant. 1998; 17 (4): 349-55
• In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW. Proc Natl Acad Sci U S A. 1998; 95 (11): 6349-54
• Congenital diaphragmatic hernia associated with aortic coarctation. Eghtesady P, Skarsgard ED, Smith BM, Robbins RC, Wexler L, Rhine WD. J Pediatr Surg. 1998; 33 (6): 943-5
• Prolongation of cardiac graft survival with anti-CD4Ig plus hCTLA4Ig in primates. Krieger NR, Yuh D, McIntyre WB, Flavin TF, Yin D, Robbins R, Fathman CG. J Surg Res. 1998; 76 (2): 174-8
• Superior vena cava syndrome after heart transplantation: percutaneous treatment of a complication of bicaval anastomoses. Sze DY, Robbins RC, Semba CP, Razavi MK, Dake MD. J Thorac Cardiovasc Surg. 1998; 116 (2): 253-61
• Paradoxical embolism of a shotgun pellet. Ikonomidis JS, Nisco SJ, Liang DH, Robbins RC. Ann Thorac Surg. 1998; 66 (2): 562-4
• Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts. Poston RS, Ennen M, Pollard J, Hoyt EG, Billingham ME, Robbins RC. J Thorac Cardiovasc Surg. 1998; 116 (3): 386-96
• The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. Vriens PW, Blankenberg FG, Stoot JH, Ohtsuki K, Berry GJ, Tait JF, Strauss HW, Robbins RC. J Thorac Cardiovasc Surg. 1998; 116 (5): 844-53
• The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10. Dosanjh AK, Elashoff D, Robbins RC. J Interferon Cytokine Res. 1998; 18 (10): 851-4
• A new large-animal model for research of graft vascular disease. Gummert JF, Ikonen T, Briffa N, Honda Y, Hayase M, Perlroth J, Kobayashi Y, Hausen B, Barlow C, Billingham ME, Fitzgerald P, Yock PG, Robbins RC, Morris RE. Transplant Proc. 1998; 30 (8): 4023
• Pleural disease in patients undergoing lung transplantation for cystic fibrosis. Dosanjh A, Jones L, Yuh D, Robbins RC. Pediatr Transplant. 1998; 2 (4): 283-7
• Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT. Leung AN, Fisher K, Valentine V, Girgis RE, Berry GJ, Robbins RC, Theodore J. Chest. 1998; 113 (2): 365-70
• Perinatal induction of immunotolerance to cardiac and pulmonary allografts. Yuh DD, Gandy KL, Reitz BA, Hoyt G, Robbins RC. J Thorac Cardiovasc Surg. 1997; 114 (1): 64-75
• Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease. Poston RS, Billingham ME, Pollard J, Hoyt EG, Robbins RC. Ann Thorac Surg. 1997; 64 (4): 1004-12
• Composite valve graft versus separate aortic valve and ascending aortic replacement: is there still a role for the separate procedure? Yun KL, Miller DC, Fann JI, Mitchell RS, Robbins RC, Moore KA, Oyer PE, Stinson EB, Shumway NE, Reitz BA. Circulation. 1997; 96 (9 Suppl): II-368-75
• A rodent model of in utero chimeric tolerance induction. Yuh DD, Gandy KL, Hoyt G, Reitz BA, Robbins RC. J Heart Lung Transplant. 1997; 16 (2): 222-30
• Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. Soghikian MV, Valentine VG, Berry GJ, Patel HR, Robbins RC, Theodore J. J Heart Lung Transplant. 1996; 15 (9): 881-7
• Upper airway obstruction caused by low-grade tracheal papillary adenocarcinoma: an usual flow-volume loop pattern. Clarke DE, Green RJ, Mark JB, Robbins RC, Raffin TA. J Thorac Cardiovasc Surg. 1996; 111 (6): 1286-8
• Primary repair of complete sternal cleft with pectoralis major muscle flaps. Snyder BJ, Robbins RC, Ramos D. Ann Thorac Surg. 1996; 61 (3): 983-4
• Twenty-year clinical experience with porcine bioprostheses. Fann JI, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB, Robbins RC, Reitz BA, Shumway NE. Ann Thorac Surg. 1996; 62 (5): 1301-11; discussion 1311-2
• Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Reichenspurner H, Girgis RE, Robbins RC, Yun KL, Nitschke M, Berry GJ, Morris RE, Theodore J, Reitz BA. Ann Thorac Surg. 1996; 62 (5): 1467-72; discussion 1472-3
• Tolerance to cardiac allografts induced in utero with fetal liver cells. Yuh DD, Gandy KL, Hoyt G, Reitz BA, Robbins RC. Circulation. 1996; 94 (9 Suppl): II304-7
• Risk factors for the development of obliterative bronchiolitis after lung transplantation. Girgis RE, Tu I, Berry GJ, Reichenspurner H, Valentine VG, Conte JV, Ting A, Johnstone I, Miller J, Robbins RC, Reitz BA, Theodore J. J Heart Lung Transplant. 1996; 15 (12): 1200-8
• Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. Robbins RC, Stinson EB. J Thorac Cardiovasc Surg. 1996; 111 (3): 586-94
• Heart retransplantation: the 25-year experience at a single institution. Smith JA, Ribakove GH, Hunt SA, Miller J, Stinson EB, Oyer PE, Robbins RC, Shumway NE, Reitz BA. J Heart Lung Transplant. 1995 Sep-Oct; 14 (5): 832-9
• Leflunomide prolongs pulmonary allograft and xenograft survival. Yuh DD, Gandy KL, Morris RE, Hoyt G, Gutierrez J, Reitz BA, Robbins RC. J Heart Lung Transplant. 1995 Nov-Dec; 14 (6 Pt 1): 1136-44
• Cardiac transplantation for hypertrophic cardiomyopathy associated with Sengers syndrome. Robbins RC, Bernstein D, Berry GJ, VanMeurs KP, Frankel LR, Reitz BA. Ann Thorac Surg. 1995; 60 (5): 1425-7
• The incidence of renal failure in one hundred consecutive heart-lung transplant recipients. Pattison JM, Petersen J, Kuo P, Valantine V, Robbins RC, Theodore J. Am J Kidney Dis. 1995; 26 (4): 643-8
• Durability of the Hancock Md bioprosthesis compared with standard aortic valve bioprosthesis. Robbins RC, Yun R, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB, Robbins RC, Reitz BA, Shumway NE.. Ann. Thorac. Surg.. 1995; (60): S221-228
• The utility of annual surveillance bronchoscopy in heart-lung transplant recipients. Girgis RE, Reichenspurner H, Robbins RC, Reitz BA, Theodore J. Transplantation. 1995; 60 (12): 1458-61
• Arterial switch and resection of hepatic hemangioendothelioma. Robbins RC, Chin C, Yun KL, Berry GJ, Bernstein D, Reitz BA. Ann Thorac Surg. 1995; 59 (6): 1575-7
• Obliterative bronchiolitis after lung and heart-lung transplantation. Reichenspurner H, Girgis RE, Robbins RC, Conte JV, Nair RV, Valentine V, Berry GJ, Morris RE, Theodore J, Reitz BA. Ann Thorac Surg. 1995; 60 (6): 1845-53
• Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. Yun KL, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB, Robbins RC, Reitz BA, Shumway NE. Ann Thorac Surg. 1995; 60 (2 Suppl): S221-8
• Long-term results of combined heart-lung transplantation: the Stanford experience. Sarris GE, Smith JA, Shumway NE, Stinson EB, Oyer PE, Robbins RC, Billingham ME, Theodore J, Moore KA, Reitz BA. J Heart Lung Transplant. 1994 Nov-Dec; 13 (6): 940-9
• Randomized, prospective assessment of bioprosthetic valve durability. Hancock versus Carpentier-Edwards valves. Sarris GE, Robbins RC, Miller DC, Mitchell RS, Moore KA, Stinson EB, Oyer PE, Reitz BA, Shumway NE. Circulation. 1993; 88 (5 Pt 2): II55-64
• Management of patients with intramural hematoma of the thoracic aorta. Robbins RC, McManus RP, Mitchell RS, Latter DR, Moon MR, Olinger GN, Miller DC. Circulation. 1993; 88 (5 Pt 2): II1-10